Life Science Investing Avidity Biosciences Announces U.S. Managed Access Program for Investigational Therapy del-zota in DMD44 19 November
Life Science Investing Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights 10 November
Life Science Investing Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG 26 October
